newsfilter
← Latest News
ACCESS Newswire·

Lexaria Issues Progress Report on First Human Clinical Study of 2021, HYPER-H21-1

Dosing Is Complete in First of Three Human Clinical Studies Hoped To Validate Lexaria's Patented Technology for Hypertension Relief Study Tested an Advanced “DehydraTECH™ 2.0” CBD Formulation Second Human Clinical Study, Hyper-H21-2, To